Over the course of the past decade, incredible progress has been made in the development of new therapies to treat the blood cancers (leukemia, lymphoma, multiple myeloma). In no area is this more apparent than in the development of different immunotherapies,
in which the power of the body’s own immune system is harnessed to fight cancer. Chimeric antigen receptor (CAR) T-cell therapy is a cutting- edge immunotherapy in which a patient’s own cells are removed, genetically modified, and infused back into the patient
to fight their blood cancer.